May 14, 2010
It is too early to assess the after effects of human papillomavirus (HPV) vaccine Gardasil in Bhutan, but the vaccine has reportedly killed a number of people around the world.
An inclusive look at the side effects of the vaccine approved in 2006 raises questions about its safety.
As of January 31, 2010, there were 49 reports of death among those who have received Gardasil in the USA alone (28 reports have been confirmed and 21 remain unconfirmed due to lack of information such as a name or contact information). Today, the death toll lies at 68 worldwide (New Zealand, United Kingdom, Australia, Spain and the USA). The Gardasil study has also allegedly led to the death of six girls in the Indian states of Andhra Pradesh and Gujarat.
Last year, the Centre for Disease Control and Prevention (CDC) reported more than 12,000 side effects after 23 million doses had been distributed. Ninety-four percent of the problems were not serious. Six percent of the cases included patients who were hospitalized, permanently disabled or dead.
Several side effects of HPV vaccine have been identified:
• Very high fever, weakness, tingling, or paralysis
• Signs of an allergic reaction, including difficulty breathing, wheezing, an unusual skin rash, itching, hives, chronic fatigue, digestive problems, dizziness and nausea, encephalitis, facial paralysis, hair loss, headaches, joint and muscle pain, loss of vision, menstrual problems, respiratory and heart problems, and seizures.
• A few girls in the country visited hospitals complaining of giddiness, headache and numbness after receiving the vaccine on May 5 but were discharged.
• Problems that occur more frequently than expected are fainting (about once every 12,000 doses) and blood clots (once every 500,000 doses).
In India, the Gardisal study conducted in children before evaluating its safety in adults, which was against the clinical trial guidelines, had led to the death of six girls. The deaths were, however, later attributed to viral fever, drowning, suicide, severe anaemia with malaria and suspected snake bite.
The Indian government suspended the vaccine in the two states of Andhra Pradesh and Gujarat, where it was to be tested for its acceptability and service delivery issues in about 32,000 girls, aged 10 to14, following reports of deaths and several complications.
Despite knowing the risks, why is Bhutan still going ahead with the vaccination programme?
Director of the public health department, Dr Ugen Dophu, said that Bhutan was not taking any risk. “We are intentionally introducing this vaccine after a thorough study,” he said, adding that the vaccine may have some side effects like any other vaccines.
The vaccine will be offered to 51,862 girls all over the country. Until last Wednesday, 41,000 girls were vaccinated.
Dr Ugen Dophu said the vaccine had caused no death according to scientific research and WHO reports. The vaccination done in the two states of India was a programme trail, like the one conducted in Paro last year, and not a vaccine trail as many seem to perceive.
He ruled out the general misconception that such vaccination studies are carried out in the developing and least developed countries. There are four stages involved – lab experimentation, advanced lab experimentation, experimentation on live animals, and partnership with developing and developed countries.
In case of HPV vaccine, all four stages have been completed, he said. Today, the vaccine is available in 108 countries worldwide. Twenty-one countries have started routine immunization. Bhutan is the 22nd country to introduce the vaccine in the routine immunization.
Normally, there is a huge benefit in participating in such a programme with the developed countries. If the medicine is found good, the participating country will get the vaccines and medicines at a very cheap rate, said the Director. “Countries should participate as the vaccines are already lab tested and experimented.”
What studies show
March 12, 2010, saw six women from around the world present documents and research about the dangers of HPV vaccines Gardasil and Cervarix to the US Food and Drug Administration (FDA). Never before have the FDA turned to members of the public regarding vaccine safety.
The reports presented detailed worldwide data proving that women and young girls have suffered severe adverse reactions, including death, after being vaccinated with the HPV vaccines.
There is a clear pattern from many countries, of girls suffering from the same side effects. Yet, the fact has not been picked up by either the committees that regulate the vaccines or the governments that sanction them. More worryingly, the six women found that there were a huge number of deaths recorded on Vaccine Adverse Event Reporting System (VAERS) after HPV vaccines.
VAERS is the reporting system used in the USA for adverse events that happen after vaccination.
Read the comment posted at the end of this article….am formulating my response. It will be good – left brain vs. right brain – intutive/common sense/wise woman thinking vs. male medical model brainwashing.
Harsh? Biased? Too friggin’ bad.